Overview
What is Intellectual Property (IP)? Does my research generate IP, and how can I protect and commercialize these technologies? Join us as we focus on the types of IP that may be generated in the course of research, and the steps that can be taken to protect and commercialize them, drawing examples from technologies utilizing, modifying, and mitigating biofilms and the microbial community.
This event serves to encourage translational research relating to biofilms and microbiomes, giving researchers an overview of the methods available in protecting and licensing the IP they have generated in the course of their work. Additionally, it provides an avenue for budding entrepreneurs and start-ups interested in this technology space to interact with and network with the technical experts in this field. Program Overview: 1.30pm - 2.00pm : Event Registration 2.00pm - 2.15pm : IP Basics and Types of IP 2.15pm - 2.30pm : Identifying Key Intangible Assets 2.30pm - 2.45pm : Patent Prosecution 2.45pm - 3.00pm : Venture Building 3.00pm - 3.15pm : Panel Discussion and Q&A 3.15pm - 4.00pm : Networking and Refreshments
Schedule
Date: 20 Nov 2023, Monday
Time: 2:00 PM - 4:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911
Speakers
Speaker's Profile:
Lai Ye Siang, IP Strategist, IPOS International
Ye Siang advises both public agencies and innovative enterprises on intellectual property management and strategy. Prior to joining IPOS International, Ye Siang was a consultant at a patent attorney firm where he advised various enterprises on intellectual property matters. He also has a rich background in the automation and automotive industries as a former engineer. Ye Siang is a Registered Management Consultant (RMC). He has a Bachelor of Engineering (Mechanical) with Honours from Nanyang Technological University, a Bachelor of Laws with Honours from the University of Tasmania and holds qualifications to practice law in Singapore. Ye Siang is also recognized as one of the world's leading IP Strategists by IAM Strategy 300.
Moderator's Profile:
Dr Wensley Louis Widjaja, Industrial Development Manager, Singapore National Biofilm Consortium
Wensley is an Industry Development Manager at Singapore National Biofilm Consortium (SNBC), connecting industry players with academic researchers in the technology domains around biofilms and the microbiome. He had experience managing patent portfolios for the research institutes in A*STAR's biomedical research council (BMRC), overseeing and evaluating technologies related to wound healing, skin diseases, drug delivery, diagnostics, cancer biomarkers and so forth. Prior to joining A*STAR, Wensley has nine years of industry experience in an R&D setting, establishing a marine biology lab, developing lab capabilities and designing in-house test methods for AkzoNobel.
Speaker's Profile:
Ho Cheng Huat, Senior Director IPM, A*STAR
Cheng Huat entered the field of intellectual property (IP) in 1993, initially as a patent engineer and later as a patent agent in 1994. In 2002, he joined A*STAR and led the IPM team that oversees ASTAR's patent portfolio until April 2022. Currently, Cheng Huat serves as an IP Advisor with A*STAR’s I&E Division. He is also seconded to SIT's Innovation and Technology Transfer Division, serving as its IP Advisor. He is a member of both the Association of Singapore Patent Agents (ASPA) and the Singapore chapter of the Licensing Executives Society (LES).
Speaker's Profile:
Christina Gee, Director IP Management, NTUitive
Christina has worked in the IP field for more than 20 years and is currently Director (IP management) at NTUitive Pte Ltd, the innovation and enterprise company of Nanyang Technological University (NTU) in Singapore. Ms Gee works with faculty members and researchers to protect NTU’s intellectual property, and with the NTUitive licensing team to support its commercialization. With her team of IP managers, Christina oversees NTU’s intellectual property and is involved in all stages of IP portfolio management – from identifying inventions, conducting due diligence checks, advising on the best mode of IP protection, managing IP contracts and filing and prosecuting patent applications through to grant and post-grant IP portfolio management.
Speaker's Profile:
Michel Birnbaum, Director of Entrepreneurship and Research Translation, NTU-SCELSE
Michel is currently Director of Entrepreneurship and Research Translation at NTU-SCELSE, working on technology commercialization via spinoffs and industry collaborations and partnerships, strategy and corporate development. He was responsible for the initial development and operations of the Singapore National Biofilm Consortium, creating partnerships in the US, UK and EU. Michel was a lecturer for the MIT-SMART ACT program where he developed and taught the course “Lab to Market”. He is co-founder and CEO of Mindsigns Health™ Inc a software brain health platform spun out of NTU. He is also advisor to a number of healthcare spinoffs involved in anti-microbials and microbiomes. Michel has held board positions with a number of technology and healthcare growth companies internationally, operational advisory roles and has managed technology & healthcare IPOs on both European markets and NASDAQ as well as M&A and investments.
